Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
adenocarcinoma, azenosertib, Century, constitutionality, Coordinator, DDR, de, dual, East, EHI, escalation, flow, half, ICH, Inspector, interoperability, LDG, LDT, lunresertib, metastatic, Middle, modification, recurrent, retention, ROU, screening, Secretary, setback, startup, undiscounted, unify, urothelial
Removed:
cell, Cowen, customary, LLC, Piper, Sandler, scheduled, waiver
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view